The effect of 5-FU and lobaplatin in the treatment of advanced hepatocellular carcinoma in serum AFP and TIP30
10.3969/j.issn.1005-1678.2016.11.019
- VernacularTitle:5－FU与洛铂对原发性肝癌晚期患者血清AFP及TIP30水平的影响
- Author:
Yang BU
;
Songning YU
- Keywords:
5-FU;
lobaplatin;
advanced hepatocellular carcinoma;
AFP;
TIP30
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(11):68-70,73
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of 5-FU and Lobaplatin in the treatment of advanced hepatocellular carcinoma in serum AFP and TIP30.Methods 86 cases of advanced hepatocellular carcinoma in our hospital form June 2014 to June 2016 were selected and randomly divided into two groups,43 cases in the control group were treated with micro catheter perfusion 5-FU sequential therapy,43 cases in the experimental group were treated more with Lobaplatin sequential therapy.The serum levels of AFP, AFP-L3, Fer, TSGF, TIP30, clinical efficacy and adverse reactions were compared before and after treatment in the two groups.Results Compared with before treatment, levels of AFP-L3,Fer,TSGF and AFP decreased in two groups, levels of TIP30 increased (P<0.05);compared with the control group,levels of AFP-L3,Fer,TSGFand AFP in the experimental group were lower(P<0.05),and levels of TIP30 were higher(P<0.05),and the total efficiency of the experimental group was higher than the control group(P<0.05),and the incidence of adverse reactions in the experimental group was lower than the control group(P<0.05).Conclusion 5-FU and Lobaplatin in the treatment of advanced hepatocellular carcinoman can effective reduce the levels of AFP,AFP-L3,Fer,TSGF,and increased the levels of TIP30.
